With Deadline Looming, Novartis Yet To Reach Fee-For-Service Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis has not entered into fee-for-service contracts with any of its distributors, Novartis Pharmaceuticals CEO Paolo Costa said March 15